It’s seldom that drug companies have the opportunity to develop a product that’s relevant to the entire world. In fact, it takes a global pandemic. IQVIA Institute for Human Data Science took on the task of estimating the financial impact of protecting the population from COVID-19, and the numbers are staggering. According to a recent FiercePharma article that discussed the figures, global vaccine sales will reach $157B by 2025. This estimate accounts for dramatic drops in the cost per dose going from an average of $22 per shot in 2021 to $9 per shot in 2023.
COVID-19 Vaccine Sales Projections are Impressive
Pharmaceutical companies that invested in coronavirus vaccine development will see big revenues.
May 4, 2021
Recommended
Recommended
Recommended
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
